Company Filing History:
Years Active: 2017
Title: Gyanesh Shukla: Innovator in Anti-Dengue Pharmaceutical Compositions
Introduction
Gyanesh Shukla is a notable inventor based in Jalaun, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-dengue treatments. His work focuses on creating effective solutions to combat dengue fever, a disease that poses a serious health risk in many regions.
Latest Patents
Gyanesh Shukla holds 1 patent related to his innovative work. His patent involves the anti-dengue activity of specific extracts. The invention provides pharmaceutical compositions that comprise these extracts and outlines processes for their preparation. This advancement is crucial in the ongoing battle against dengue fever.
Career Highlights
Gyanesh Shukla is associated with Sun Pharmaceutical Industries Limited, a leading company in the pharmaceutical sector. His role in the company allows him to contribute to the development of vital health solutions. His expertise and dedication to research have positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Gyanesh has collaborated with notable colleagues, including Pradip Kumar Bhatnagar and Chandra Kant Katiyar. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical field.
Conclusion
Gyanesh Shukla's contributions to anti-dengue pharmaceutical compositions highlight his commitment to improving public health. His innovative work and collaborations continue to pave the way for advancements in the treatment of dengue fever.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.